For instance, inhibition of AXL reduces the phosphorylation of M2 isoform of pyruvate kinase (PKM2) at Y105, which decreases glycolysis and enhances chemosensitivity of human ovarian cancer cells to cisplatin [101]. This evidence concerns the gene AXL and ovarian carcinoma.